IP Library › Granted Patent US 9,833,448
Granted Patent B2
US 9,833,448 · App. 15/293,569 · Granted Dec 5, 2017

Piperidinone carboxamide azaindane CGRP receptor antagonists

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,833,448
App. No.
15/293,569
Granted
Dec 5, 2017
Kind
B2
Abstract

The present invention is directed to piperidinone carboxamide azaindane derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

Claims (2)

1. A method of treating migraine in a mammalian patient in need of such treatment which method comprises administering to the patient a therapeutically effective amount of a pharmaceutical composition comprising the compound of Formula II:

or a pharmaceutically acceptable salt thereof.

Assignments (2)
MERGER Recorded Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2017
From: BELL, IAN M.; FRALEY, MARK E.; GALLICCHIO, STEVEN N.; GINNETTI, ANTHONY; MITCHELL, HELEN J.; PAONE, DANIEL V.; STAAS, DONNETTE D.; WANG, CHENG; ZARTMAN, C.BLAIR; STEVENSON, HEATHER E.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 042765/0619 →